Purpose: In this study, we investigated the profile of microRNAs (miRNAs) contained in exosomes secreted in the serum of patients with papillary thyroid cancer (PTC). Methods: Exosome were isolated by adding ExoQuick Exosome Precipitation Solution. Dynamic light scattering (DLS) and western blotting analysis were used to ensure the quality of exosomes. The expression levels of miRNAs were investigated using custom-designed TaqMan Advanced miRNA Array Cards in the screening cohort and using specific TaqMan Advanced MicroRNA Assays in the validation cohort. Results: We identified miR24-3p, miR146a-5p, miR181a-5p and miR382-5p with different expression levels in two different series of 56 and 58 PTC patients as compared with healthy controls. Significant differences in the expression of three PTC exosomal miRNAs, depending on the presence of lymph node metastasis, were detected in only one PTC series. When comparing the expression levels of some PTC-specific exosomal miRNAs with those of the same miRNAs circulating free of any encapsulation, we found a significant correlation for only miR24-3p, suggesting that only select miRNAs are secreted in exosomes. Conclusions: Our findings demonstrate that four miRNAs are differently secreted in the exosomes of PTC patients, whereas no conclusive results were found to characterize PTCs with lymph node metastasis, suggesting caution in the use of circulating exosomal miRNA expression levels as lymph node metastasis biomarkers. Further investigation into the mechanisms governing miRNA secretion in tumor cells are required.

Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer / Capriglione, F.; Verrienti, A.; Celano, M.; Maggisano, V.; Sponziello, M.; Pecce, V.; Gagliardi, A.; Giacomelli, L.; Aceti, V.; Durante, C.; Bulotta, S.; Russo, D.. - In: ENDOCRINE. - ISSN 1355-008X. - 1:75(2022), pp. 185-193. [10.1007/s12020-021-02847-2]

Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer

Verrienti A.
Co-primo
;
Sponziello M.;Pecce V.;Giacomelli L.;Aceti V.;Durante C.;
2022

Abstract

Purpose: In this study, we investigated the profile of microRNAs (miRNAs) contained in exosomes secreted in the serum of patients with papillary thyroid cancer (PTC). Methods: Exosome were isolated by adding ExoQuick Exosome Precipitation Solution. Dynamic light scattering (DLS) and western blotting analysis were used to ensure the quality of exosomes. The expression levels of miRNAs were investigated using custom-designed TaqMan Advanced miRNA Array Cards in the screening cohort and using specific TaqMan Advanced MicroRNA Assays in the validation cohort. Results: We identified miR24-3p, miR146a-5p, miR181a-5p and miR382-5p with different expression levels in two different series of 56 and 58 PTC patients as compared with healthy controls. Significant differences in the expression of three PTC exosomal miRNAs, depending on the presence of lymph node metastasis, were detected in only one PTC series. When comparing the expression levels of some PTC-specific exosomal miRNAs with those of the same miRNAs circulating free of any encapsulation, we found a significant correlation for only miR24-3p, suggesting that only select miRNAs are secreted in exosomes. Conclusions: Our findings demonstrate that four miRNAs are differently secreted in the exosomes of PTC patients, whereas no conclusive results were found to characterize PTCs with lymph node metastasis, suggesting caution in the use of circulating exosomal miRNA expression levels as lymph node metastasis biomarkers. Further investigation into the mechanisms governing miRNA secretion in tumor cells are required.
2022
Extracellular vesicles; gene expression; microRNA; thyroid cancer exosomes
01 Pubblicazione su rivista::01a Articolo in rivista
Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer / Capriglione, F.; Verrienti, A.; Celano, M.; Maggisano, V.; Sponziello, M.; Pecce, V.; Gagliardi, A.; Giacomelli, L.; Aceti, V.; Durante, C.; Bulotta, S.; Russo, D.. - In: ENDOCRINE. - ISSN 1355-008X. - 1:75(2022), pp. 185-193. [10.1007/s12020-021-02847-2]
File allegati a questo prodotto
File Dimensione Formato  
Durante_Serum-microRNA_2022.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 974.21 kB
Formato Adobe PDF
974.21 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1574428
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 7
social impact